Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Nov 30, 2025 → Feb 28, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| MERCK & CO | 0 | 10,915 | 10,915 | 5.99% | $1.35M |
| IONIS PHARMACEUTICALS INC | 0 | 3,918 | 3,918 | 1.41% | $317.95K |
| QIAGEN NV | 0 | 6,309 | 6,309 | 1.39% | $314.19K |
| REPLIGEN CORP | 0 | 2,204 | 2,204 | 1.26% | $283.72K |
| PENUMBRA INC | 0 | 750 | 750 | 1.14% | $258.29K |
| ROYALTY PHARMA PLC | 0 | 4,939 | 4,939 | 1.01% | $228.23K |
| BRIDGEBIO PHARMA INC | 0 | 3,115 | 3,115 | 0.92% | $207.09K |
| STRUCTURE THERAPEUTICS INC ADR | 0 | 1,092 | 1,092 | 0.30% | $68.77K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 3,468 | 0 | -3,468 | 0.00% | -$527.69K |
| VEEVA SYSTEMS-A | 1,793 | 0 | -1,793 | 0.00% | -$430.84K |
| DANAHER CORP | 1,673 | 0 | -1,673 | 0.00% | -$379.40K |
| NOVO NORDISK-B | 6,936 | 0 | -6,936 | 0.00% | -$341.65K |
| ALNYLAM PHARMACEUTICALS INC | 481 | 0 | -481 | 0.00% | -$217.04K |
| IRHYTHM TECHNOLOGIES INC | 883 | 0 | -883 | 0.00% | -$166.01K |
| WEST PHARMACEUTICAL SVCS INC | 555 | 0 | -555 | 0.00% | -$153.87K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| LILLY ELI and CO | 2,483 | 2,619 | 136 | 12.20% | $84.77K |
| JOHNSON&JOHNSON | 6,602 | 7,357 | 755 | 8.10% | $461.61K |
| ASTRAZENECA PLC | 6,564 | 6,923 | 359 | 6.41% | $231.23K |
| BOSTON SCIENTIFIC CORP | 15,320 | 17,062 | 1,742 | 5.81% | -$244.99K |
| INTUITIVE SURGICAL INC | 1,899 | 2,003 | 104 | 4.47% | -$80.51K |
| GUARDANT HEALTH INC | 7,253 | 8,978 | 1,725 | 3.73% | $56.66K |
| HOYA CORP | 4,273 | 4,523 | 250 | 3.63% | $176.73K |
| ARGENX SE SPONSORED ADR | 1,014 | 1,061 | 47 | 3.60% | -$111.05K |
| CENCORA INC | 1,950 | 2,056 | 106 | 3.39% | $45.71K |
| LONZA GROUP -REG | 903 | 953 | 50 | 2.94% | $45.92K |
| AGILENT TECHNOLOGIES INC | 5,110 | 5,409 | 299 | 2.91% | -$127.84K |
| DEXCOM INC | 4,794 | 8,247 | 3,453 | 2.68% | $301.30K |
| ROIVANT SCIENCES LTD | 16,724 | 17,375 | 651 | 2.23% | $154.81K |
| METTLER-TOLEDO INTL INC | 283 | 293 | 10 | 1.77% | -$17.47K |
| APOGEE THERAPEUTICS INC | 3,782 | 5,225 | 1,443 | 1.62% | $93.56K |
| Sartorius Stedim Biotech S.A. | 1,587 | 1,658 | 71 | 1.59% | -$23.37K |
| INSMED INC | 1,767 | 1,846 | 79 | 1.22% | -$91.47K |
| Goldman Sachs Treasury Obligations Fund Institutional Class | 213,017 | 245,420 | 32,403 | 1.09% | $32.40K |
| NATERA INC | 1,104 | 1,137 | 33 | 1.05% | -$27.10K |
| XENON PHARMACEUTICALS INC | 5,226 | 5,393 | 167 | 1.03% | -$567 |
| UNITEDHEALTH GRP | 752 | 775 | 23 | 1.01% | -$20.70K |
| CYTOKINETICS INC | 3,282 | 3,546 | 264 | 0.98% | -$2.97K |
| RHYTHM PHARMACEUTICALS INC | 948 | 2,150 | 1,202 | 0.88% | $95.95K |
| CG ONCOLOGY INC | 2,634 | 3,187 | 553 | 0.83% | $69.29K |
| ARCELLX INC | 1,501 | 1,623 | 122 | 0.82% | $75.54K |
| GENEDX HOLDINGS CORP-A | 1,540 | 1,664 | 124 | 0.59% | -$124.47K |
| ULTRAGENYX PHARMA INC | 3,347 | 3,619 | 272 | 0.37% | -$31.66K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| THERMO FISHER SCIENTIFIC INC | 2,088 | 2,001 | -87 | 4.62% | -$190.91K |
| ABBOTT LABS | 7,995 | 6,078 | -1,917 | 3.13% | -$323.38K |
| MADRIGAL PHARMACEUTICALS INC | 664 | 466 | -198 | 0.89% | -$195.08K |
| REVOLUTION MEDICINES INC | 2,505 | 1,159 | -1,346 | 0.52% | -$76.55K |
| INSULET CORP | 2,593 | 432 | -2,161 | 0.47% | -$741.87K |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.